Chunguang Wang

NO.218 Ziqiang Street
Changchun, 130041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Association between multimarkers of metabolic malnutrition and inflammation and risk of chronic obstructive pulmonary disease and lung function: a prospective cohort study of UK biobank.

Association between multimarkers of metabolic malnutrition and inflammation and risk of chronic obstructive pulmonary disease and lung function: a prospective cohort study of UK biobank.

Journal: Nutrition & metabolism

Published: June 23, 2025

Gilteritinib overcomes second‑generation TKIs resistance in ALK‑rearranged non‑small‑cell lung cancer by inhibiting PD‑L1 and CD8 co‑expression.

Gilteritinib overcomes second‑generation TKIs resistance in ALK‑rearranged non‑small‑cell lung cancer by inhibiting PD‑L1 and CD8 co‑expression.

Journal: International journal of molecular medicine

Published: June 17, 2025

Surgical intervention for patients with fibrinopurulent pleural empyema and acute respiratory failure: a case report.

Surgical intervention for patients with fibrinopurulent pleural empyema and acute respiratory failure: a case report.

Journal: Postgraduate medicine

Published: January 01, 2025

Establishment of a prognostic nomogram for evaluating non-adjuvant therapy in patients with stage I to III esophageal cancer: a population-based study.

Establishment of a prognostic nomogram for evaluating non-adjuvant therapy in patients with stage I to III esophageal cancer: a population-based study.

Journal: Journal of thoracic disease

Published: August 23, 2024

Correction to: A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: A case report.

Correction to: A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: A case report.

Journal: Investigational new drugs

Published: July 27, 2022

A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: a case report.

A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: a case report.

Journal: Investigational new drugs

Published: April 01, 2022

Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth.

Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth.

Journal: Journal for immunotherapy of cancer

Published: May 11, 2020

Aldehyde Dehydrogenase, Liver Disease and Cancer.

Aldehyde Dehydrogenase, Liver Disease and Cancer.

Journal: International journal of biological sciences

Published: November 20, 2019

Hepatocellular carcinoma in the noncirrhotic liver: a literature review.

Hepatocellular carcinoma in the noncirrhotic liver: a literature review.

Journal: European journal of gastroenterology & hepatology

Published: April 23, 2019

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy.

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy.

Journal: Oncotarget

Published: May 06, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026